Baxter International reported first-quarter 2026 results with sales of US$2,701 million, a net loss of US$15 million, and a diluted loss per share of US$0.03, while reaffirming full-year guidance for ...

Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short ...

Baxter International, a global healthcare products company with more than $15 billion in annual revenue, kicked off 2023 with the new year’s resolution of becoming streamlined and nimble. Five months ...

(Reuters) -Baxter International is bringing its hurricane-hit IV manufacturing facility in North Carolina back online in stages, with a goal of restoring 90% to 100% of customer needs by the end of ...

Baxter's first-quarter results included a 1% sales decline on an organic basis, against a tough comparable period, and adjusted earnings per share of $0.36 on a continuing basis, which came in above ...

Remember Baxter’s Baxalta biopharmaceutical spinoff in 2015? The Illinois company is auctioning off businesses again and has reportedly attracted several suitors. Celltrion and Thermo Fisher ...

Provides updates on Baxter’s 2030 Corporate Responsibility Commitment and Goals and reinforces the company’s commitment to transparent reporting “Baxter employees across the globe are connected by our ...

Looming tariffs plus a CEO transition equals high uncertainty around Baxter International BAX today. Yet given the deep discount at which the shares trade, we think this cheap stock is an attractive ...